Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03996148Phase 4
Key facts
Phase 4, randomised, open-label trial of propofol and dexmedetomidine in carotid artery stenosis (CAS) (3 arms), sponsored by Cooper University Health Care. Primary endpoint: Time to First Postoperative Neurological Examination at 1 hour. Started Sep 2017; status: completed.
Remifentanil + Propofol + Desflurane
Remifentanil + Dexmedetomidine + Desflurane
Remifentanil + Desflurane (Control)
Adults undergoing carotid endarterectomy surgery who are able to undergo a preoperative neurological exam and do not have significant comorbidities like dementia, severe CAD, or morbid obesity.
Time to First Postoperative Neurological Examination
Beyond the preview
Full results, competitive context and analysis are in the Gosset platform.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03996148.